论文部分内容阅读
BACKGROUND: Studies have shown that percutaneous coronary intervention combined with tirofiban therapy could improve the blood supply of heart and reduce cardiac infarction.This study aimed to study the efficacy and safety of low-dose tirofiban in the treatment of elderly patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention.